Michael Rosenblatt

Exec V-P & Chief Med Officer, Merck & Co.

Companies

Azenta Life SciencesBoard member Sep 11, 2018 to Feb 13, 2024¹
Axcella Health (United States)Board member May 23, 2022 to May 23, 2022²
Rubius Therapeutics (United States)Board member Jul 17, 2018 to May 13, 2022³
Merck & Co.Exec V-P & Chief Med Officer Dec 16, 2009 to May 12, 2016⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAzenta Life Sciences, Board member
2
SEC EDGARAxcella Health (United States), Board member
3
SEC EDGARRubius Therapeutics (United States), Board member
4
SEC EDGARMerck & Co., Exec V-P & Chief Med Officer